New World monkey efficacy trials for malaria vaccine development: critical path or detour?
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Trends in Parasitology
- Vol. 17 (9) , 419-425
- https://doi.org/10.1016/s1471-4922(01)02012-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Major histocompatibility complex class I genes in primates: co‐evolution with pathogensImmunological Reviews, 1999
- Genetic analysis of host–parasite coevolution in human malariaPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1997
- Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of KenyaVaccine, 1996
- Clinical Immunity to Plasmodium falciparum Malaria Is Associated with Serum Antibodies to the 19-kDa C-Terminal Fragment of the Merozoite Surface Antigen, PfMSP-lThe Journal of Infectious Diseases, 1996
- Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiersVaccine, 1994
- A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.The Journal of Experimental Medicine, 1990
- Induction of protective immunity against experimental infection with malaria using synthetic peptidesNature, 1987
- Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparumJournal of Molecular Biology, 1987
- Identification of a strain-specific malarial antigen exposed on the surface of Plasmodium falciparum-infected erythrocytes.The Journal of Experimental Medicine, 1984
- Immunization against blood-stage rodent malaria using purified parasite antigensNature, 1981